← Leaderboards
Darlene H Brunzell
Virginia Commonwealth University
$3,114,387
Attributed
$4,136,469
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–21$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,136,469 · 5
By mechanism
R01$1,635,771 · 1
UH3$1,562,048 · 1
UH2$482,117 · 1
P30$300,981 · 1
R03$155,552 · 1
Top collaborators
- Kenneth Alan Perkins3 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Gordon D Ginder$21,192,432
- Thomas Evan Eissenberg$31,184,471
- Tamas S Gal$737,860
- Harry D Bear$5,428,734
- Danielle Shafer$253,878
Others in their field
Top investigators on “Nicotinic Receptors”
- Marina R. Picciotto · Yale University$25,752,267
- Henry A. Lester · California Institute Of Technology$20,487,222
- Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute$17,620,368
- Paul J Kenny · Icahn School Of Medicine At Mount Sinai$17,249,281
- Lindsay H Burns · Cassava Sciences, Inc$16,572,741
- Linda P Dwoskin · University Of Kentucky$15,438,153
Research focus
Nicotinic ReceptorsSmoking CessationTobacco DependenceAffectNicotine DependenceGrantAreaBiologicalBaseNovel TherapeuticsInnovationClinical TrialsClinical ResearchSmokerRewardsNicotineLeadInfusion ProceduresBrainGeneticAnticancer ResearchCancer ControlCancer Health DisparityCancer Clinical Trial
Grant awards (18)
Cancer Prevention and Control$27,967
P30 · FY2021 · CA · contact PI
Cancer Prevention and Control$57,535
P30 · FY2020 · CA · contact PI
Cancer Prevention and Control$61,969
P30 · FY2019 · CA · contact PI
Cancer Prevention and Control$61,885
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control$12,843
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control$11,990
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control$5,070
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control$61,722
P30 · FY2017 · CA · contact PI
Medication development of a novel therapeutic for smoking cessation$771,686
UH3 · FY2015 · TR · contact PI
Nicotinic contributions to affective behavior$325,610
R01 · FY2015 · DA · contact PI
Medication development of a novel therapeutic for smoking cessation$790,362
UH3 · FY2014 · TR · contact PI
Nicotinic contributions to affective behavior$330,683
R01 · FY2014 · DA · contact PI
Medication development of a novel therapeutic for smoking cessation$482,117
UH2 · FY2013 · TR · contact PI
Nicotinic contributions to affective behavior$317,563
R01 · FY2013 · DA · contact PI
Nicotinic contributions to affective behavior$330,904
R01 · FY2012 · DA · contact PI
Nicotinic contributions to affective behavior$331,011
R01 · FY2011 · DA · contact PI
nAChR subunit contributions to nicotine dependent behaviors$73,010
R03 · FY2008 · DA · contact PI
nAChR subunit contributions to nicotine dependent behaviors$82,542
R03 · FY2007 · DA · contact PI